Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  DexCom, Inc.    DXCM   US2521311074

DEXCOM, INC. (DXCM)

7
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/21/2015 04/22/2015 04/23/2015 04/24/2015 04/27/2015 Date
70.33(c) 69.28(c) 70.56(c) 69.43(c) 67.56(c) Last
562 122 626 621 1 041 155 650 241 879 408 Volume
+2.79% -1.49% +1.85% -1.60% -2.69% Change
More quotes
Financials ($)
Sales 2015 361 M
EBIT 2015 3,42 M
Net income 2015 3,66 M
Debt 2015 -
Yield 2015 -
Sales 2016 490 M
EBIT 2016 40,8 M
Net income 2016 34,7 M
Debt 2016 64,0 M
Yield 2016 -
PER 2015 1 626,00
PER 2016 166,82
EV / Sales 2015 15,2x
EV / Sales 2016 11,4x
Capitalization 5 498 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company.The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
04/22 DEXCOM : reg; Introduces Apps That Enable the First Ever Continuous Glucose Moni..
04/22 DEXCOM : Announces Upcoming Conference Presentations
04/18 DEXCOM : Unveils Apps for Continuous Glucose Monitoring on the Apple Watch
04/15 DEXCOM : Introduces Apps for Continuous Glucose Monitoring on the Apple Watch
04/10 DEXCOM : reg; Introduces Apps That Enable the First Ever Continuous Glucose Moni..
04/10 DEXCOM : Schedules First Quarter 2015 Earnings Release and Conference Call for A..
03/02 DEXCOM : Issues Fourth Quarter Financial Results
02/28 DEXCOM : Schedules Upcoming Conference Presentations
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
04:48pDJMedtronic in FDA Consent Decree Over Its SynchroMed Infusion Pump
04:33pDJMedtronic in FDA Consent Decree Over SynchroMed Infusion Pump -- Update
04:07p MEDTRONIC : must stop most sales of Synchromed drug pumps (FDA)
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
02/28 DEXCOM : Post Earnings Pullback To Offer Buying Opportunity
02/25 DexCom's (DXCM) CEO Kevin Sayer on Q4 2014 Results - Earnings Call Transcript
02/25 DexCom beats by $0.05, beats on revenue
02/24 Notable earnings after Wednesday's close
02/20 NEXT WEEK IN BIOTECH : Arena And Vivus Report, Radiesse And Avedro Ad Comms


Comments 
Advertisement
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF